One hundred years of research in the pathogenesis of pulmonary hypertension.
作者信息
Zaiman Ari, Fijalkowska Iwona, Hassoun Paul M, Tuder Rubin M
机构信息
Department of Pathology, Division of Cardiopulmonary Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
出版信息
Am J Respir Cell Mol Biol. 2005 Nov;33(5):425-31. doi: 10.1165/rcmb.F307.
Abstract
摘要
相似文献
1
One hundred years of research in the pathogenesis of pulmonary hypertension.肺动脉高压发病机制的百年研究
Am J Respir Cell Mol Biol. 2005 Nov;33(5):425-31. doi: 10.1165/rcmb.F307.
2
Evangelos Michelakis.
Circ Res. 2018 Sep 28;123(8):938-941. doi: 10.1161/CIRCRESAHA.118.314005.
3
Indian Childhood Cirrhosis - A Forgotten Entity.印度儿童肝硬化——一个被遗忘的病症。
Indian Pediatr. 2017 Mar 15;54(3):239-240. doi: 10.1007/s13312-017-1037-y.
4
[Professor Dr. sc. med.Walter Schilling (14th July 1932–7th April 2014)].
Pneumologie. 2014 Jun;68(6):432. doi: 10.1055/s-0034-1365744. Epub 2014 Jun 10.
5
Historical perspective: surgery for chronic thromboembolic disease.
Semin Thorac Cardiovasc Surg. 2006 Fall;18(3):218-22. doi: 10.1053/j.semtcvs.2006.09.007.
6
[Development of interest of pulmonary hypertension in the Czech Republic].
Vnitr Lek. 2014 Apr;60(4):271-4.
7
Pulmonary arterial hypertension: yesterday, today, tomorrow.肺动脉高压：昨日、今日、明日。
Circ Res. 2014 Jun 20;115(1):109-14. doi: 10.1161/CIRCRESAHA.115.301132.
8
[Treatment of primary pulmonary hypertension: one hundred years of search and disappointments].
Ter Arkh. 1998;70(9):16-8.
9
Diagnosis and management of pulmonary hypertension over the past 100 years.
Respir Med. 2007 Mar;101(3):389-98. doi: 10.1016/j.rmed.2006.11.022. Epub 2007 Jan 11.
10
[Pulmonary hypertension].[肺动脉高压]
Nihon Kokyuki Gakkai Zasshi. 2003 Jun;Suppl:171-81.
引用本文的文献
1
The critical roles of caveolin-1 in lung diseases.小窝蛋白-1在肺部疾病中的关键作用。
Front Pharmacol. 2024 Sep 24;15:1417834. doi: 10.3389/fphar.2024.1417834. eCollection 2024.
2
Unilateral Lung Removal in Combination with Monocrotaline or SU5416 in Rodents: A Reliable Model to Mimic the Pathology of the Human Pulmonary Hypertension.单侧肺切除联合野百合碱或 SU5416 在啮齿类动物中：模拟人类肺动脉高压病理的可靠模型。
Methods Mol Biol. 2024;2803:173-185. doi: 10.1007/978-1-0716-3846-0_13.
3
Tensions in Taxonomies: Current Understanding and Future Directions in the Pathobiologic Basis and Treatment of Group 1 and Group 3 Pulmonary Hypertension.分类学中的紧张局势：1 型和 3 型肺动脉高压的病理生物学基础和治疗的当前理解和未来方向。
Compr Physiol. 2023 Jan 30;13(1):4295-4319. doi: 10.1002/cphy.c220010.
4
A Protocol for Fabrication and on-Chip Cell Culture to Recreate PAH-Afflicted Pulmonary Artery on a Microfluidic Device.一种在微流控装置上制造和进行芯片上细胞培养以重建受肺动脉高压影响的肺动脉的方案。
Micromachines (Basel). 2022 Sep 7;13(9):1483. doi: 10.3390/mi13091483.
5
Single-cell RNA sequencing reveals that mutation regulates right ventricular function genes.单细胞RNA测序显示，突变调控右心室功能基因。
Eur Respir J. 2022 Jul 7;60(1). doi: 10.1183/13993003.00327-2021. Print 2022 Jul.
6
Critical Role of Caveolin-1 Loss/Dysfunction in Pulmonary Hypertension.窖蛋白-1 缺失/功能障碍在肺动脉高压中的关键作用。
Med Sci (Basel). 2021 Sep 22;9(4):58. doi: 10.3390/medsci9040058.
7
Mouse model of experimental pulmonary hypertension: Lung angiogram and right heart catheterization.实验性肺动脉高压小鼠模型：肺血管造影和右心导管检查。
Pulm Circ. 2021 Sep 8;11(4):20458940211041512. doi: 10.1177/20458940211041512. eCollection 2021 Oct-Dec.
8
PTEN as a Therapeutic Target in Pulmonary Hypertension Secondary to Left-heart Failure: Effect of HO-3867 and Supplemental Oxygenation.PTEN 在左心衰竭性肺动脉高压中的治疗靶点：HO-3867 和补充氧疗的作用。
Cell Biochem Biophys. 2021 Sep;79(3):593-607. doi: 10.1007/s12013-021-01010-y. Epub 2021 Jun 16.
9
Pulmonary-arterial-hypertension (PAH)-on-a-chip: fabrication, validation and application.肺动脉高压（PAH）芯片：制作、验证和应用。
Lab Chip. 2020 Sep 21;20(18):3334-3345. doi: 10.1039/d0lc00605j. Epub 2020 Aug 4.
10
Resistin family proteins in pulmonary diseases.抵抗素家族蛋白与肺部疾病。
Am J Physiol Lung Cell Mol Physiol. 2020 Sep 1;319(3):L422-L434. doi: 10.1152/ajplung.00040.2020. Epub 2020 Jun 17.
本文引用的文献
1
Primary pulmonary hypertension.
J Pathol Bacteriol. 1946 Oct;58(4):687-97. doi: 10.1002/path.1700580410.
2
Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease.使用骨髓来源的内皮样祖细胞挽救野百合碱诱导的肺动脉高压：细胞与内皮型一氧化氮合酶基因联合治疗在已确诊疾病中的疗效
Circ Res. 2005 Mar 4;96(4):442-50. doi: 10.1161/01.RES.0000157672.70560.7b. Epub 2005 Feb 3.
3
Gene microarray analysis of peripheral blood cells in pulmonary arterial hypertension.肺动脉高压患者外周血细胞的基因芯片分析
Am J Respir Crit Care Med. 2004 Oct 15;170(8):911-9. doi: 10.1164/rccm.200312-1686OC. Epub 2004 Jun 23.
4
Pathologic assessment of vasculopathies in pulmonary hypertension.肺动脉高压中血管病变的病理学评估
J Am Coll Cardiol. 2004 Jun 16;43(12 Suppl S):25S-32S. doi: 10.1016/j.jacc.2004.02.033.
5
Clinical classification of pulmonary hypertension.肺动脉高压的临床分类
J Am Coll Cardiol. 2004 Jun 16;43(12 Suppl S):5S-12S. doi: 10.1016/j.jacc.2004.02.037.
6
Clinical efficacy of sildenafil in primary pulmonary hypertension: a randomized, placebo-controlled, double-blind, crossover study.西地那非治疗原发性肺动脉高压的临床疗效：一项随机、安慰剂对照、双盲、交叉研究。
J Am Coll Cardiol. 2004 Apr 7;43(7):1149-53. doi: 10.1016/j.jacc.2003.10.056.
7
Primary pulmonary hypertension. I. Clinical and hemodynamic study.原发性肺动脉高压。I. 临床与血流动力学研究。
Am J Med. 1951 Dec;11(6):686-705. doi: 10.1016/0002-9343(51)90020-4.
8
Expression of human herpesvirus 8 in primary pulmonary hypertension.人类疱疹病毒8型在原发性肺动脉高压中的表达
N Engl J Med. 2003 Sep 18;349(12):1113-22. doi: 10.1056/NEJMoa035115.
9
The pathology of hypertensive pulmonary vascular disease; a description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects.高血压性肺血管疾病的病理学；肺动脉结构改变六级描述，特别提及先天性心脏间隔缺损。
Circulation. 1958 Oct;18(4 Part 1):533-47. doi: 10.1161/01.cir.18.4.533.
10
The effect of acetylcholine on pulmonary vascular resistance and left atrial pressure in mitral stenosis.乙酰胆碱对二尖瓣狭窄时肺血管阻力和左心房压力的影响。
Br Heart J. 1957 Apr;19(2):279-86. doi: 10.1136/hrt.19.2.279.
Zotero 插件